603231 Solbar Ningbo Protein Technology
- 14.27
- -0.30-2.06%
Solbar Ningbo Protein Technology News
Why Solbar Ningbo Protein Technology's (SHSE:603231) Shaky Earnings Are Just The Beginning Of Its Problems
2024 Semi-Annual Report
2024 Semi-Annual Report Summary
Sobot Protein (603231.SH) released its first-half performance, with a net income of 70.798 million yuan, a year-on-year decrease of 1.98%.
Sorfa protein (603231.SH) released its 2024 interim report, with revenue of 0.772 billion yuan...
Sobey Protein (603231.SH): The non-deductible net income for the first half of the year was 63.5157 million yuan, a year-on-year decrease of 10.25%.
On August 29th, GeLongHui announced its semi-annual report. In the first half of 2024, the company achieved revenue of 772.006 million yuan, a decrease of 8.91% compared to the same period last year. The net income attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 63.5157 million yuan, a decrease of 10.25% compared to the same period last year.
Sobao Protein (603231.SH): Quan Hongchan did not endorse the company's products.
On August 9th, Gelunhui reported that Soubaoprotein (603231.SH) stated on the investor interaction platform that Ms. Quanhongchan has not currently endorsed the company's products.
Sorbay Protein (603231.SH): intends to establish overseas wholly-owned subsidiaries and subsidiaries.
On July 4th, Gelunhui reported that, according to operational development needs, the board of directors agreed that the company plans to establish a wholly-owned subsidiary, SOLBAR INTERNATIONAL PTE. LTD., in Singapore with its own (self-raised) capital to invest no more than 15 million yuan (or equivalent foreign currency) for trading and import and export of existing and extended products. And agreed to invest no more than RMB 25 million (or equivalent foreign currency) in Germany through its wholly-owned subsidiary, SOLBAR INTERNATIONAL, with its own (self-raised) capital.
SuoBao Protein (603231.SH) will distribute a dividend of 0.5 yuan per share in 2023, with a record date of June 27th.
Sobio Pharmaceutical (603231.SH) announced that the company will implement annual equity distribution in 2023, and distribute dividends per share...
Sobey Protein (603231.SH): 959,300 restricted shares will be released on June 17.
On June 7th, Gelunhui reported that the total number of shares of Souke Protein (603231.SH) to be listed this time is 959,300. The date of the share listing is June 17th, 2024.
Sorobao Protein (603231.SH): Suduo Technology is a shareholder of the company
Gelonghui, May 8, 丨 Suobao Protein (603231.SH) said on the investor interactive platform that the company is not engaged in synthetic biotechnology-related business; Suduo Technology (Shenzhen) Co., Ltd. is the company's shareholder.
Sorobao protein (603231.SH): not involved in the low-altitude economy
Gelonghui April 30 丨 Suobao Protein (603231.SH) said on the investor interactive platform that the company's main business is R&D, production and sales of soy protein. The company is currently not involved in the low-altitude economy sector.
Suobao Protein (603231.SH) announced its 2023 annual results, with net profit of 150 million yuan, a year-on-year decrease of 10.52%
Sorobo Protein (603231.SH) disclosed its 2023 annual report, and the company achieved revenue of 17 in 2023...
Solbar Ningbo Protein Technology Co., Ltd.'s (SHSE:603231) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
SOBAO PROTEIN (603231.SH): No collaboration with Wahaha
Gelonghui March 14 | Suobao Protein (603231.SH) said on the investor interactive platform that the company has no cooperation with Wahaha; the company's main business is R&D, production and sales of soy protein series products. Soy protein products are widely used in food and beverages.
Sorobao protein (603231.SH): The company's products can be used as a nitrogen source for biofermentation to prepare APIs
Gelonghui, Feb. 21丨Suobao Protein (603231.SH) said on the investor interactive platform that the company's products can be used as a nitrogen source for biofermentation to prepare APIs.
Sorobao protein (603231.SH): non-genetically modified soybean oil mainly targets customers for B-side customers
Gelonghui, January 25 | Suobao Protein (603231.SH) said on the investor interactive platform that currently the company's non-GMO soybean oil is mainly aimed at B-side customers; small amounts of non-GMO soybean oil in small packages are sold by some dealers around Dongying.
Sorobao protein (603231.SH): No specialty dietary products are produced or sold
Gelonghui, January 24 | Suobao Protein (603231.SH) said on the investor interactive platform that the company has not yet produced or sold specialty dietary products, and that some of the company's products can be used as raw materials for specialty dietary products.
SOBAO PROTEIN (603231.SH): The company's soy protein can be used as an ingredient in pet food
Gelonghui January 24 丨 Suobao Protein (603231.SH) said on the investor interactive platform that the company's soy protein can be used as an ingredient in pet food.
Sorobao Protein (603231.SH): Plans to use part of the capital raised to increase capital to a wholly-owned subsidiary
On January 15, Gelonghui | Suobao Protein (603231.SH) announced that it plans to increase the capital of its wholly-owned subsidiary Biotechnology with part of the capital raised from the initial public offering of shares. The amount of capital increase is RMB 264.8175 million. After the capital increase was completed, Biotech is still a wholly-owned subsidiary of the company, and the company holds 100% of the shares.
Sorobao protein (603231.SH): The product can be used in meat products, imitation meat products, snack food, beverages and other industries
Gelonghui, January 10 | Suobao Protein (603231.SH) said on the investor interactive platform that the company's products can be used in meat products, imitation meat products, snack food, beverages and other industries.
Analysis
Price Target
No Data
No Data